EXCEDRIN (MIGRAINE RELIEF) Drug Patent Profile

✉ Email this page to a colleague

When do Excedrin (migraine Relief) patents expire, and when can generic versions of Excedrin (migraine Relief) launch?

Excedrin (migraine Relief) is a drug marketed by Haleon Us Holdings and is included in one NDA.

The generic ingredient in EXCEDRIN (MIGRAINE RELIEF) is acetaminophen; aspirin; caffeine. There are sixty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; aspirin; caffeine profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for EXCEDRIN (MIGRAINE RELIEF)?
What are the global sales for EXCEDRIN (MIGRAINE RELIEF)?
What is Average Wholesale Price for EXCEDRIN (MIGRAINE RELIEF)?

Summary for EXCEDRIN (MIGRAINE RELIEF)

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	4
Clinical Trials:	1
DailyMed Link:	EXCEDRIN (MIGRAINE RELIEF) at DailyMed

Drug patent expirations by year for EXCEDRIN (MIGRAINE RELIEF)

Recent Clinical Trials for EXCEDRIN (MIGRAINE RELIEF)

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Albert Einstein Healthcare Network	Phase 4

See all EXCEDRIN (MIGRAINE RELIEF) clinical trials

Pharmacology for EXCEDRIN (MIGRAINE RELIEF)

Drug Class	Central Nervous System Stimulant Methylxanthine Nonsteroidal Anti-inflammatory Drug Platelet Aggregation Inhibitor
Mechanism of Action	Cyclooxygenase Inhibitors
Physiological Effect	Central Nervous System Stimulation Decreased Platelet Aggregation Decreased Prostaglandin Production

US Patents and Regulatory Information for EXCEDRIN (MIGRAINE RELIEF)

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Haleon Us Holdings	EXCEDRIN (MIGRAINE RELIEF)	acetaminophen; aspirin; caffeine	TABLET;ORAL	020802-001	Jan 14, 1998		OTC	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for EXCEDRIN (MIGRAINE RELIEF)

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Haleon Us Holdings	EXCEDRIN (MIGRAINE RELIEF)	acetaminophen; aspirin; caffeine	TABLET;ORAL	020802-001	Jan 14, 1998	⤷ Sign Up	⤷ Sign Up
Haleon Us Holdings	EXCEDRIN (MIGRAINE RELIEF)	acetaminophen; aspirin; caffeine	TABLET;ORAL	020802-001	Jan 14, 1998	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for EXCEDRIN (MIGRAINE RELIEF)

See the table below for patents covering EXCEDRIN (MIGRAINE RELIEF) around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Denmark	0994714		⤷ Sign Up
Taiwan	565447		⤷ Sign Up
World Intellectual Property Organization (WIPO)	9903475		⤷ Sign Up
Argentina	016337	USO DE UNA COMBINACION DE N-(4-HIDROXIFENIL)ACETAMIDA (ACETOAMINOFENOL,APAP); ACIDO 2-(ACETILOXI)BENZOICO (ASPIRINA ASA) Y 3,7-DIHIDRO-1, 3, 7-TRIMETIL-1H-PURINA-2,6-DIONA (CAFEINA, CAF) Y COMPOSICION FARMACEUTICA QUE COMPRENDE DICHA COMBINACION	⤷ Sign Up
Portugal	994714		⤷ Sign Up
Germany	69814636		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for EXCEDRIN (MIGRAINE RELIEF)

Recent Clinical Trials for EXCEDRIN (MIGRAINE RELIEF)

Pharmacology for EXCEDRIN (MIGRAINE RELIEF)

Make Better Decisions: Try a trial or see plans & pricing